Validating TDP1 as an Inhibition Target for Lipophilic Nucleoside Derivative in Human Cells. [PDF]
Int J Mol SciChernyshova IA +8 more
europepmc +1 more source
Comparison of drug regimens for recurrent or metastatic cervical cancer: a systematic review and network meta-analysis. [PDF]
Front ImmunolZhou J, Ye W, Ranarisoa SN, Tian L.
europepmc +1 more source
Survival Benefit of Temozolomide Plus Irinotecan as Second-Line Therapy in Small Cell Lung Cancer: A Retrospective Single-Center Study. [PDF]
J Clin MedAcar O +4 more
europepmc +1 more source
The Efficacy and Safety of Nab-Paclitaxel Plus Anlotinib in Small-Cell Lung Cancer for Second-Line Therapy. [PDF]
Thorac CancerTian LJ, Zhou FF, Dai M, Liu JL, Guo QS.
europepmc +1 more source
Efficacy and tolerability of first-line treatment regimens for extensive-stage small cell lung cancer - a grade-assessed network meta-analysis of randomized controlled trials. [PDF]
BMC CancerNajah Q +7 more
europepmc +1 more source
Health economic evaluation of Mirvetuximab soravtansine for the treatment of FRĪ±-positive, platinum resistant ovarian cancer in Germany. [PDF]
J Cancer Res Clin OncolJanke FF +4 more
europepmc +1 more source
Programmable shunt valves with a "virtual off" for intrathecal chemotherapy delivery in children with high-grade CNS tumors and hydrocephalus. [PDF]
Childs Nerv SystDvir R +9 more
europepmc +1 more source
Learning drug synergy through environment-conditioned feature modulation. [PDF]
BioinformaticsJin S +6 more
europepmc +1 more source